OneDigital Investment Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
VPM
VCM
EC
OneDigital Investment Advisors's JAZZ Position: Q1 2026 in Review
OneDigital Investment Advisors reduced its Jazz Pharmaceuticals (JAZZ) stake by 16% in Q1 2026, selling an estimated $100K and leaving 3,022 shares worth $571K. The position accounts for 0.01% of the portfolio, ranked #886.
OneDigital Investment Advisors first reported a position in JAZZ in Q1 2018 and has held it in 10 quarters since. The position peaked at $611K in Q4 2025. 571 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- OneDigital Investment Advisors held 3,022 shares of Jazz Pharmaceuticals worth $571K as of Q1 2026.
- OneDigital Investment Advisors sold 573 Jazz Pharmaceuticals shares in Q1 2026, an estimated $100K.
- Jazz Pharmaceuticals made up 0.01% of OneDigital Investment Advisors's portfolio in Q1 2026, its #886 holding.
- OneDigital Investment Advisors first reported a position in Jazz Pharmaceuticals in Q1 2018 and has held it in 10 quarters since.
- OneDigital Investment Advisors's Jazz Pharmaceuticals position peaked at $611K in Q4 2025.
- 571 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on OneDigital Investment Advisors's 13F filing for Q1 2026, filed 8 May 2026.